Omnic (Tamsulosin Hydrochloride)

Tamsulosin is an alpha‑1 blocker used to manage conditions related to prostate enlargement and lower urinary tract symptoms.

• Benign prostatic hyperplasia (BPH): improves urine flow and reduces bladder outlet obstruction.
• Lower urinary tract symptoms (LUTS) associated with BPH: lessens urgency, frequency, and nocturia.
• Acute urinary retention secondary to BPH (post‑catheterization): facilitates successful trial without catheter.

• Tamsulosin selectively antagonizes alpha‑1A and alpha‑1D adrenergic receptors located in the smooth muscle of the prostate, bladder neck, and urethra. By blocking these receptors, it prevents norepinephrine‑induced contraction, leading to relaxation of the urinary outflow tract, decreased resistance, and enhanced urinary stream. The drug exhibits high affinity for the α1‑A subtype, which predominates in prostatic tissue, while sparing vascular α1‑B receptors, thereby minimizing systemic blood pressure changes. This selectivity contributes to its favorable safety profile in treating urinary obstruction.

Tamsulosin may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects

• Dizziness or light‑headedness.
• Headache.
• Nasal congestion or runny nose.
• Abnormal ejaculation, including retrograde ejaculation.

Serious or Rare Side Effects

• Severe hypotension or syncope.
• Priapism.
• Allergic reactions such as rash, angioedema, or anaphylaxis.
• Intra‑operative floppy iris syndrome during cataract surgery.

When prescribing Omnic, clinicians should consider several safety measures.

• Assess cardiovascular status: monitor for dizziness or hypotension, especially after the first dose.
• Avoid concomitant use with potent CYP3A4 inhibitors: may increase plasma levels.
• Use caution in patients with hepatic impairment: dose adjustment may be required.
• Do not discontinue abruptly in patients undergoing surgery: may affect intra‑operative iris behavior.
• Inform patients about possible ejaculatory changes: discuss sexual side effects.
• Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Tamsulosin can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Potent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may raise tamsulosin levels.
• Alpha‑blockers (e.g., prazosin, doxazosin): additive hypotensive effect.
• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): increased risk of hypotension.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce efficacy.

• Diuretics: may enhance orthostatic hypotension.
• Other antihypertensives: monitor blood pressure for additive effects.